Tag Archives: EXEL

Saturday’s Highlights at Noon: Exelixis (EXEL), Mallinckrodt (MNK), Stratasys (SSYS), Sangamo Biosciences (SGMO), Karyopharm Therapeutics (KPTI)

So far Saturday, January 25, NASDAQ is down -5.75% and the S&P is down -3.67%. Let’s take a look at this morning’s most active stocks and their recent analyst insights; Exelixis (EXEL – Research Report), Mallinckrodt (MNK – Research Report),

Friday’s Highlights at Noon: Mallinckrodt (MNK), Exelixis (EXEL), Goodrich Petroleum (GDP), Clovis Oncology (CLVS), Alcoa (AA)

So far Friday, January 24, NASDAQ is down -5.19% and the S&P is down -3.33%. Here are this morning’s most active stocks: Mallinckrodt (MNK – Research Report), Exelixis (EXEL – Research Report), Goodrich Petroleum (GDP – Research Report), Clovis Oncology

Exelixis (EXEL) Received its Third Buy in a Row

After William Blair and Merrill Lynch gave Exelixis (NASDAQ: EXEL) a Buy rating last month, the company received another Buy, this time from Cowen & Co. Analyst Yaron Werber maintained a Buy rating on Exelixis today and set a price

Analysts Are Bullish on These Healthcare Stocks: Exelixis (EXEL), Hologic (HOLX)

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Exelixis (EXEL – Research Report) and Hologic (HOLX – Research Report) with bullish sentiments. Exelixis (EXEL) In a report released today, Jason

Cowen & Co. Remains a Buy on Exelixis (EXEL)

In a report released yesterday, Yaron Werber from Cowen & Co. maintained a Buy rating on Exelixis (EXEL – Research Report), with a price target of $23.00. The company’s shares closed last Monday at $18.32. According to TipRanks.com, Werber is

Exelixis (EXEL) Gets a Buy Rating from Needham

Needham analyst Chad Messer maintained a Buy rating on Exelixis (EXEL – Research Report) today and set a price target of $30.00. The company’s shares closed last Monday at $17.86. According to TipRanks.com, Messer is a 4-star analyst with an